Exact Sciences has launched a new genetic test that uses a blood or saliva sample to predict the risk of developing various cancers.

The Madison-based diagnostics company yesterday rolled out the Riskguard hereditary cancer test, which will be available for order starting March 12. It can provide insights on familial risk and specific genetic changes for 10 common cancers: colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine.

Brandie Leach, senior director of medical affairs for Exact Sciences, says the test can help patients understand their risk of developing these cancers “to inform screening, treatment and risks” to other family members.

Click here to read the full article.